Protocol of CRISPR-Cas9 knockout screens for identifying ferroptosis regulators

Xin Yang1, Shoufu Duan1, Zhiming Li1

  • 1Institute for Cancer Genetics, and Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.

STAR Protocols
|December 4, 2023
PubMed

Insights

This study details a CRISPR-Cas9 screening protocol to find regulators of ferroptosis, an iron-dependent cell death. The method efficiently identifies key genes controlling ferroptosis, aiding therapeutic development.

Area of Science:

  • Biochemistry
  • Genetics
  • Cell Biology

Background:

  • Ferroptosis is an iron-dependent programmed cell death involving lipid peroxidation.
  • It holds therapeutic potential for various human diseases.
  • Identifying ferroptosis regulators is crucial for developing targeted therapies.

Purpose of the Study:

  • To establish a CRISPR-Cas9 loss-of-function screening protocol.
  • To identify novel regulators of ferroptosis induced by different agents.
  • To provide an efficient method for target discovery and validation.

Main Methods:

  • CRISPR-Cas9 loss-of-function screen.
  • Library amplification and drug treatment.
  • High-throughput sequencing and bioinformatics analysis using MAGeCK.

Main Results:

  • A robust protocol for identifying ferroptosis regulators was developed.
  • The screen enables discovery of genes modulating ferroptosis.
  • The method allows for efficient verification of potential therapeutic targets.

Conclusions:

  • The described protocol facilitates systematic identification of ferroptosis regulators.
  • This approach can accelerate the discovery of new therapeutic strategies targeting ferroptosis.
  • Efficient target validation is a key feature of this screening method.